Companies / Celularity Inc

Celularity Inc

Nasdaq: CELUCIK 1752828FLORHAM PARK, NJ

Financials · FY2025

Revenue$26.55M
Net income$-91.72M
Total debt$59.64M
Cash$6.17M
Diluted EPS$-3.59
Shares outstanding28.9M

Ownership

28.9M shares outstanding · as of Apr 28, 2026
14.4%Insiders
Ownership
Insiders14.43%4,177,597
Institutions7.62%2,205,894
Public float77.95%22,562,470

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 5

View all →
Insider% of sharesShares
Hariri Robert JCEOChief Executive Officer · Director
9.86%2,853,553
1.80%520,021
1.36%394,150
0.88%256,026
0.53%153,847

Institutional holders 36

View all →

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q1 2026
as of
Geode Capital Management, LLC
13F manager
AddCommon Stock$41.1K+31K
+19.28%
191,076
0.66% of shares
low
Q4 2025
as of
Bank of America Corp /De
13F manager
TrimCommon Stock$-41.0K-37K
-99.92%
28
<0.01% of shares
low
Q2 2026
as of
BlackRock, Inc.
13F manager
TrimCommon Stock$-23.0K-38K
-33.52%
76,359
0.26% of shares
low
Q4 2025
as of
IFP Advisors, Inc
13F manager
TrimCommon Stock$-1.1K-1K
-8.33%
11,000
0.04% of shares
low
Q3 2024
as of
Danske Bank A/S
13F manager
NewCommon Stock$3+1
1
<0.01% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Lincoln Alternative Strategies LLCPassive13G/A0

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
CELUCommon StockEquity151190204BBG00P2RTT34